Editorial: biomarkers in HBV and prediction of treatment response

Aliment Pharmacol Ther. 2021 Jan;53(2):332-333. doi: 10.1111/apt.16171.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antiviral Agents* / therapeutic use
  • Biomarkers
  • Hepatitis B Surface Antigens*
  • Hepatitis B virus
  • Humans

Substances

  • Antiviral Agents
  • Biomarkers
  • Hepatitis B Surface Antigens